^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    SNX20 overexpression

    i
    Other names: SNX20, Sorting Nexin 20, SLIC1, Selectin Ligand-Interactor Cytoplasmic 1
    Entrez ID:
    124460
    Related biomarkers:
    Expression
    Associations

    News

    Trials
    over2years
    DNA methylation-regulated SNX20 overexpression correlates with poor prognosis, immune cell infiltration, and low-grade glioma progression. (PubMed, Aging (Albany NY))
    Depletion of SNX20 significantly inhibits glioma cell proliferation and migration abilities. This is the first study to identify SNX20 as a new potential prognostic biomarker and characterize the functional roles of SNX20 in the progression of LGG, and provides a novel potential diagnostic and therapeutic biomarker for LGG in the future.
    Journal • IO biomarker • Epigenetic controller
    |
    SNX20 (Sorting Nexin 20)
    |
    SNX20 overexpression
    3years
    SNX20AR/MiRNA-301a-3p/SNX20 Axis Associated With Cell Proliferation and Immune Infiltration in Lung Adenocarcinoma. (PubMed, Front Mol Biosci)
    Our findings suggested that ncRNAs play a crucial role in the regulatory network of SNX20. Collectively, our findings demonstrate the suppressor roles of the SNX20AR/miRNA-301a-3p/SNX20 axis in Lung Adenocarcinoma, represent that SNX20 have the potential of as an effective therapeutic target in future.
    Journal
    |
    SNX20 (Sorting Nexin 20)
    |
    SNX20 overexpression